NCT00743405View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 2, 2008

Primary Completion Date

December 15, 2008

Study Completion Date

December 15, 2008

Conditions
Cognitive Disorders
Interventions
DRUG

GSK1034702

Oral or liquid

DRUG

Placebo

To match GSK1034702

Trial Locations (1)

NW10 7NS

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00743405 - Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects | Biotech Hunter | Biotech Hunter